Portal de investigación
SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Poveda, A
- Martinez, V
- Serrano, C
- Sevilla, I
- Lecumberri, MJ
- Estival, A
- Vicente, D
- Rubio, J
- Martin-Broto, J
Grupos
Abstract
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the digestive tract, and this disease has served as a paradigmatic model for successful rational development of targeted therapies. The introduction of tyrosine kinase inhibitors with activity against KIT/PDGFRA in both localized and advanced stages has remarkably improved the survival in a disease formerly deemed resistant to all systemic therapies. The Spanish Society of Medical Oncology (SEOM) guidelines provide a multidisciplinary and updated consensus for the diagnosis and treatment of GIST patients. We strongly encourage that the managing of these patients should be performed within multidisciplinary teams in reference centers.
Datos de la publicación
- ISSN/ISSNe:
- 1699-048X, 1699-3055
- Tipo:
- Article
- Páginas:
- 1221-1228
- PubMed:
- 27896638
- Factor de Impacto:
- 0,774 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
Clinical & Translational Oncology SPRINGER INT PUBL AG
Citas Recibidas en Web of Science: 21
Documentos
- No hay documentos
Filiaciones
Keywords
- GIST; Imatinib; Sunitinib; Regorafenib
Campos de Estudio
Cita
Poveda A,Martinez V,Serrano C,Sevilla I,Lecumberri MJ,DE BEVERIDGE RD,Estival A,Vicente D,Rubio J,Martin J. SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016). Clin Transl Oncol. 2016. 18. (12):p. 1221-1228. IF:2,353. (3).